Mealey's (February 4, 2019, 11:04 AM EST) -- WASHINGTON, D.C. — The Federal Circuit U.S. Court of Appeals on Feb. 1 rejected a challenge to an adverse inter partes review (IPR) by the Patent Trial and Appeal Board, agreeing...
Federal Circuit Confirms Patentability Of Epilepsy Treatment
To view the full article, register now.
Try for FREE for fourteen days
Already a subscriber? Click here to login